# A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation

> **NCT00211094** · PHASE3 · COMPLETED · sponsor: **Alza Corporation, DE, USA** · enrollment: 1320 (actual)

## Conditions studied

- Ejaculation

## Interventions

- **DRUG:** Dapoxetine

## Key facts

- **NCT ID:** NCT00211094
- **Lead sponsor:** Alza Corporation, DE, USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2004-06
- **Target enrollment:** 1320 (ACTUAL)
- **Last updated:** 2011-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211094, "A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00211094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*